Indoco Remedies rises as its arm commences commercial production of Pharmaceutical Intermediates
Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel
Indoco Remedies is currently trading at Rs. 337.90, up by 2.55 points or 0.76% from its previous closing of Rs. 335.35 on the BSE.
The scrip opened at Rs. 349.80 and has touched a high and low of Rs. 349.80 and Rs. 337.80 respectively. So far 2300 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 416.95 on 01-Jan-2024 and a 52 week low of Rs. 307.00 on 26-Apr-2023.
Last one week high and low of the scrip stood at Rs. 349.80 and Rs. 323.25 respectively. The current market cap of the company is Rs. 3133.57 crore.
The promoters holding in the company stood at 58.74%, while Institutions and Non-Institutions held 21.25% and 20.0 % respectively.
Indoco Remedies’ Wholly Owned Subsidiary -- Warren Remedies has commenced its commercial production on March 24, 2024 from its Greenfield manufacturing facility located at Aurangabad, Maharashtra to manufacture Pharmaceutical Intermediates and Active Pharmaceutical Ingredients (APIs). The said manufacturing facility will provide the company requisite capabilities and edge in meeting demand of APIs.
Indoco Remedies is engaged in the manufacturing and marketing of formulations (finished dosage forms) and active pharmaceutical ingredients (APIs) in India.
